Literature DB >> 22240460

Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008.

Stephen A Berry1, John A Fleishman, Richard D Moore, Kelly A Gebo.   

Abstract

INTRODUCTION: Hospitalization rates for comorbid conditions among persons living with HIV in the current highly active antiretroviral therapy era are unknown.
METHODS: Hospitalization data from 2001 to 2008 were obtained on 11,645 adults receiving longitudinal HIV care at 4 geographically diverse US HIV clinics within the HIV Research Network. Modified clinical classification software from the Agency for Healthcare Research and Quality assigned primary ICD-9 codes into diagnostic categories. Analysis was performed with repeated measures negative binomial regression.
RESULTS: During 2001 to 2008, the rate of AIDS-defining illness (ADI) hospitalizations declined from 6.7 to 2.7 per 100 person-years, incidence rate ratio per year, 0.89 (0.87, 0.91). Among the other diagnostic categories with average rates >2 per 100 person-years, cardiovascular hospitalizations increased over time [1.07 (1.03, 1.11)], whereas non-AIDS-defining infection [0.98 (0.96, 1.00)], psychiatric [0.96 (0.93, 1.00)], and gastrointestinal/liver [0.96 (0.92, 1.00)] were slightly decreasing or stable. Although less frequent overall, renal and pulmonary admissions also increased over time in univariate and multivariate analyses. Of all diagnostic categories, ADI admissions had the longest mean length of stay, 10.5 days. DISCUSSION: ADI hospitalizations have continued to decline in recent years but are still relatively frequent and potentially costly given long lengths of stay. Increases or stability in the rates of chronic end-organ disease admissions imply a need for broader medical knowledge among individual clinicians and/or teams who care for persons living with HIV and a need for long-term access to medications for these conditions.

Entities:  

Mesh:

Year:  2012        PMID: 22240460      PMCID: PMC3299935          DOI: 10.1097/QAI.0b013e318246b862

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  32 in total

1.  Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.

Authors:  Marian E Betz; Kelly A Gebo; Ed Barber; Peter Sklar; John A Fleishman; Erin D Reilly; W Christopher Mathews
Journal:  Med Care       Date:  2005-09       Impact factor: 2.983

2.  Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.

Authors:  Joel E Gallant; Michelle A Parish; Jeanne C Keruly; Richard D Moore
Journal:  Clin Infect Dis       Date:  2005-03-17       Impact factor: 9.079

3.  Severe premature coronary artery disease with protease inhibitors.

Authors:  K Henry; H Melroe; J Huebsch; J Hermundson; C Levine; L Swensen; J Daley
Journal:  Lancet       Date:  1998-05-02       Impact factor: 79.321

4.  Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.

Authors:  K A Gebo; M Diener-West; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

5.  Quality of HIV care provided by nurse practitioners, physician assistants, and physicians.

Authors:  Ira B Wilson; Bruce E Landon; Lisa R Hirschhorn; Keith McInnes; Lin Ding; Peter V Marsden; Paul D Cleary
Journal:  Ann Intern Med       Date:  2005-11-15       Impact factor: 25.391

6.  Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.

Authors:  Kelly A Gebo; John A Fleishman; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

7.  Longitudinal assessment (1995-2003) of hospitalizations of HIV-infected patients within a geographical population in Canada.

Authors:  H B Krentz; S Dean; M J Gill
Journal:  HIV Med       Date:  2006-10       Impact factor: 3.180

8.  Hospital and outpatient health services utilization among HIV-infected patients in care in 1999.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2002-05-01       Impact factor: 3.731

9.  Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

Authors:  Murielle Mary-Krause; Laurent Cotte; Anne Simon; Maria Partisani; Dominique Costagliola
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

10.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18
View more
  65 in total

1.  Comparison of HIV outcomes for patients linked at hospital versus community-based clinics.

Authors:  Asher J Schranz; Kathleen A Brady; Florence Momplaisir; Joshua P Metlay; Alisa Stephens; Baligh R Yehia
Journal:  AIDS Patient Care STDS       Date:  2015-02-09       Impact factor: 5.078

2.  HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis.

Authors:  David B Hanna; Wendy S Post; Jennifer A Deal; Howard N Hodis; Lisa P Jacobson; Wendy J Mack; Kathryn Anastos; Stephen J Gange; Alan L Landay; Jason M Lazar; Frank J Palella; Phyllis C Tien; Mallory D Witt; Xiaonan Xue; Mary A Young; Robert C Kaplan; Lawrence A Kingsley
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

3.  Health Outcomes of HIV-Infected People with Mental Illness.

Authors:  Baligh R Yehia; Alisa J Stephens-Shield; Florence Momplaisir; Lynne Taylor; Robert Gross; Benoit Dubé; Karen Glanz; Kathleen A Brady
Journal:  AIDS Behav       Date:  2015-08

4.  Thirty-day hospital readmissions for adults with and without HIV infection.

Authors:  S A Berry; J A Fleishman; R D Moore; K A Gebo
Journal:  HIV Med       Date:  2015-07-14       Impact factor: 3.180

5.  An Inpatient HIV Support Nurse to Promote Engagement in Outpatient HIV Care.

Authors:  Elizabeth Holmes; David Thompson; Deborah Michell; Janessa M Smith; Meredith Ilana Zoltick; Kelly A Gebo; Richard D Moore; Lois Eldred; Andrea Ciaranello; Stephen A Berry
Journal:  J Assoc Nurses AIDS Care       Date:  2019 Mar-Apr       Impact factor: 1.354

6.  Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans.

Authors:  Engi F Attia; Kathleen A McGinnis; Laura C Feemster; Kathleen M Akgün; Adeel A Butt; Christopher J Graber; Michael J Fine; Matthew B Goetz; Maria C Rodriguez-Barradas; Margaret A Pisani; Hilary A Tindle; Sheldon T Brown; Guy W Soo Hoo; David Rimland; Cynthia L Gibert; Laurence Huang; Matthew S Freiberg; Catherine L Hough; Kristina Crothers
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

7.  Prevalence and Predictors of Hospitalizations Among HIV-Infected and At-Risk HIV-Uninfected Women.

Authors:  Anna L Hotton; Kathleen M Weber; Ronald C Hershow; Kathryn Anastos; Peter Bacchetti; Elizabeth T Golub; Deborah Gustafson; Alexandra M Levine; Mary Young; Mardge H Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

8.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

9.  Thirty-day hospital readmission rate among adults living with HIV.

Authors:  Stephen A Berry; John A Fleishman; Baligh R Yehia; P Todd Korthuis; Allison L Agwu; Richard D Moore; Kelly A Gebo
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

10.  Trends in Cardiovascular Disease Mortality Among Persons With HIV in New York City, 2001-2012.

Authors:  David B Hanna; Chitra Ramaswamy; Robert C Kaplan; Jorge R Kizer; Kathryn Anastos; Demetre Daskalakis; Regina Zimmerman; Sarah L Braunstein
Journal:  Clin Infect Dis       Date:  2016-07-20       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.